Skip to main content
Clinical Trials/NL-OMON29642
NL-OMON29642RecruitingNot Applicable

The effect Imagery Rescripting early in treatment on the course of Borderline Personality Disorder Severity during Schema Therapy.

o external funding. This study is supported by the participating mental health institutes and the Department of Clinical Psychology, University of Amsterdam0 sites73 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
73

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Borderline PD based on the DSM-5 as primary diagnosis (assessed with SCID-II or SCID-5-P) and a score of 20 or above on the Borderline Personality Disorder Severity index (BPDSI).
  • - Age 18-65
  • - Ability to understand, read, write and speak Dutch.

Exclusion Criteria

  • - Alcohol or drug dependence needing clinical detox. (After 3 months of abstinence participation is possible).
  • - Comorbid psychotic disorder (when > 1 year in full remission inclusion is possible).
  • - Antisocial personality disorder with a history of physical interpersonal violence in the last two years.
  • - DSM-5 Bipolar disorder, type 1 (current or past) . If there has been no manic episode the last year patients will be included.
  • - Acute suicide risk
  • - IQ < 80
  • - Schema Therapy of any kind (e.g., individual, group, inpatient, outpatient, day treatment) in the past year.
  • - Patients should not start with any form of psychological treatment or medication during screening or during the study’s treatment or waitlist period. Medication should be on a stable level for 3 months, if not stopped. (Non-PD focused supportive treatment may be continued during wait and screening, but not during the study treatment and study 1-year follow-up period)
  • - Not able to plan (group) therapy sessions of 90 minutes and individual sessions of 45-60 minutes once a week during 2 years within the treatment period.

Investigators

Sponsor
o external funding. This study is supported by the participating mental health institutes and the Department of Clinical Psychology, University of Amsterdam

Similar Trials